|
CKAP5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.016800E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.843500E-03 |
| Normal-vs-Stage2 |
6.364100E-02 |
| Normal-vs-Stage3 |
6.668300E-02 |
| Normal-vs-Stage4 |
4.355200E-03 |
| Stage1-vs-Stage2 |
9.847000E-01 |
| Stage1-vs-Stage3 |
5.829200E-01 |
| Stage1-vs-Stage4 |
4.712600E-01 |
| Stage2-vs-Stage3 |
7.365800E-01 |
| Stage2-vs-Stage4 |
5.507000E-01 |
| Stage3-vs-Stage4 |
2.736200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.322600E-03 |
| Normal-vs-AfricanAmerican |
5.900500E-03 |
| Normal-vs-Asian |
5.075900E-03 |
| Caucasian-vs-AfricanAmerican |
3.227200E-01 |
| Caucasian-vs-Asian |
4.217000E-01 |
| AfricanAmerican-vs-Asian |
7.241400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.741600E-02 |
| Normal-vs-Female |
1.984150E-03 |
| Male-vs-Female |
3.484600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.584340E-03 |
| Normal-vs-Age(41-60Yrs) |
3.692300E-02 |
| Normal-vs-Age(61-80Yrs) |
2.469900E-02 |
| Normal-vs-Age(81-100Yrs) |
9.860200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.745770E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.936600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.420200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.370200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.520200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.458000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.366000E-01 |
| Classical-VS-Follicular |
1.48859999993256E-07 |
| Classical-VS-Other |
1.612040E-01 |
| Classical-VS-Normal |
6.13440000000187E-05 |
| Tall-VS-Follicular |
4.175700E-04 |
| Tall-VS-Other |
1.106040E-01 |
| Tall-VS-Normal |
2.660600E-03 |
| Follicular-VS-Other |
7.442600E-01 |
| Follicular-VS-Normal |
4.455200E-01 |
| Other-VS-Normal |
9.742200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.786150E-01 |
| Normal-vs-N1 |
2.265200E-01 |
| N0-vs-N1 |
7.624200E-01 |
|
|
